Semaglutide’s Potential and Challenges in Managing Adolescent Metabolic Health in the U.S.
Written by , Updated on March 27th, 2025
Reading Time: 3 minutesIntroduction to Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising treatment for type 2 diabetes and obesity in adults. Its efficacy in managing blood glucose levels and promoting weight loss has sparked interest in its potential use among adolescents, a demographic increasingly affected by metabolic disorders. This article delves into the opportunities and challenges associated... Read more »
